RARE2023 Feedback Form
The 5th International Conference on Rare Diseases
EACCME CME Feedback Form - please complete ASAP. Completion of this form is a mandatory requirement in order to receive your CME credits.
OK
*
1.
QUALITY OF THE EVENT. How useful for your professional activity did you find this event?
(Required.)
Extremely Useful
Useful
Fairly useful
Not useful
If this activity was not useful, please explain why:
*
2.
Q1 a) PROGRAM: What was your overall impression of this event regarding the Program?
(Required.)
Excellent
Useful
Fairly useful
Not useful
What was the best aspect of this event?
What was the worst aspect of this event?
*
3.
Q1 b) ORGANISATION: What was your overall impression of this event regarding the Organisation?
(Required.)
Excellent
Useful
Fairly useful
Not useful
What was the best aspect of this event?
What was the worst aspect of this event?
*
4.
RELEVANCE OF THE EVENT. Did the event fulfil your educational goals and expected learning outcomes?
(Required.)
Very much
Somewhat
Not much
Not at all
Undecided
*
5.
Was the presented information well balanced and consistently supported by a valid scientific evidence base?
(Required.)
Very much
Somewhat
Not much
Not at all
Undecided
*
6.
How useful to you personally was each session:
a) Opening Keynote Lecture: Rare Diseases in Hungary – HAE (Hereditary Angioedema) as a Model
(Required.)
Extremely useful
Useful
Fairly useful
Not useful
Undecided/DNA
*
7.
b) Session 1: Rare Diseases Presented as Common Disorders or When "What's Common is Common" Leads to Misdiagnosis and Tragedies
(Required.)
Extremely useful
Useful
Fairly useful
Not useful
Undecided/DNA
*
8.
c) Session 2: Innovative Treatments for Rare Diseases in Hematology
(Required.)
Extremely useful
Useful
Fairly useful
Not useful
Undecided/DNA
*
9.
d) Session 3: International Networking in Rare Diseases
(Required.)
Extremely useful
Useful
Fairly useful
Not useful
Undecided/DNA
*
10.
e) Session 4: Innovative Therapies
(Required.)
Extremely useful
Useful
Fairly useful
Not useful
Undecided/DNA
*
11.
f) Special Lecture: Establishing a Rare Disease Center in a Developing Country
(Required.)
Extremely useful
Useful
Fairly useful
Not useful
Undecided/DNA
*
12.
g) Session 5: Rare Diseases Where Early Treatment Matters
(Required.)
Extremely useful
Useful
Fairly useful
Not useful
Undecided/DNA
*
13.
h) Session 6: 80% of the Rare Diseases are Genetic
(Required.)
Extremely useful
Useful
Fairly useful
Not useful
Undecided/DNA
*
14.
i) Session 7: Biosimilars, Innovative Therapies, Small Molecules and Palliative Care in Rare Diseases
(Required.)
Extremely useful
Useful
Fairly useful
Not useful
Undecided/DNA
*
15.
j) Session 8: The Patients' Voices in Rare Diseases
(Required.)
Extremely useful
Useful
Fairly useful
Not useful
Undecided/DNA
*
16.
SUITABILITY OF FORMATS USED DURING EVENT. Was there adequate time available for discussions, questions & answers and learner engagement?
(Required.)
Yes always/almost always
Yes, sometimes
Only rarely
Never
Undecided
Can you indicate any innovative elements during the activity?
*
17.
WAYS THE EVENT AFFECTS CLINICAL PRACTICE. Will the information y ou learnt be implemented in your practice?
(Required.)
Very much
Somewhat
Not much
Not at all
Undecided
Can you provide ONE example how this event will influence your future practice?
*
18.
COMMERCIAL BIAS. Did all the faculty members provide their potential conflict of interest declaration with the sponsor(s) as a second slide of their presentation?
(Required.)
Yes, all
Yes, for the majority
Yes, but only a small part
No
Undecided/Don't know
Can you provide an example of biased presentation in this activity?
*
19.
Do you agree that the information was overall free of commercial and other bias?
(Required.)
Strongly agree
Rather agree
Rather disagree
Strongly disagree
Undecided/Don't know
20.
Each participant should claim only those hours of credit that he/she actually spent in the educational activity.
30 November 2023 - 5.5 Credits
1 December 2023 - 6.0 Credits
*
21.
Please add your full name (required in order to issue the CME certificate)
(Required.)
Current Progress,
0 of 21 answered